Insider Trading & Ownership - ARCH Venture Fund XII L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ARCH Venture Fund XII L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-15
Purchase
2024-02-20
5:38 pm
Prime Medicine Inc.PRMEARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
10% Owner
3,200,000$6.25$20,000,00015,456,594
(Indirect)
View
2023-11-13
Purchase
2023-11-15
6:54 pm
Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
10% Owner
35,010$11.77$412,1404,131,207
(Indirect)
View
2023-11-08
Purchase
2023-11-13
7:00 pm
Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
10% Owner
140,605$10.98$1,543,5634,096,197
(Indirect)
View
2023-11-03
Purchase
2023-11-07
6:59 pm
Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
10% Owner
95,694$11.49$1,099,9453,955,592
(Indirect)
View
2023-09-28
Purchase
2023-09-29
6:53 pm
Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
10% Owner
76,511$13.68$1,046,8483,859,898
(Indirect)
View
2023-09-26
Purchase
2023-09-27
8:18 pm
Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
10% Owner
58,504$11.97$700,4643,783,387
(Indirect)
View
2023-09-22
Purchase
2023-09-25
9:38 pm
Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
10% Owner
100,740$11.19$1,127,0643,724,883
(Indirect)
View
2023-09-19
Purchase
2023-09-20
06:16 am
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner
1,500,000$17$25,500,0003,624,143
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-08
Other
2023-12-12
7:53 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner
1,879,654$032,424,564
(Indirect)
View
2023-09-19
Conversion
2023-09-20
06:16 am
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner
17,424,704$03,624,143
(Indirect)
View

Ownership
2023-09-14
9:29 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner
0$028,045,420
(Indirect)
View